Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record no longer displays the 2023-08-18 date associated with “Certification/Extension First Posted.”
    Difference
    0.1%
    Check dated 2026-11-14T16:58:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page displays the ClinicalTrials.gov record for a completed Phase 3 study of fostamatinib for COVID-19, including its eligibility criteria, locations, interventions, and outcome measures.
    Difference
    66%
    Check dated 2026-11-07T17:35:53.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 on a page displaying a 403 Forbidden response.
    Difference
    0.2%
    Check dated 2026-10-31T17:16:50.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T20:23:08.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.3%
    Check dated 2026-10-17T22:00:38.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site release identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.3%
    Check dated 2026-10-10T22:00:52.000Z thumbnail image

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.